“SAFETY AND TOLERABILITY OF ULTRA-SHORT COURSE RIFAPENTINE AND ISONIAZID (1HP) FOR PREVENTION OF TUBERCULOSIS IN HIV UNINFECTED INDIVIDUALS.”